About this trial
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
Eligibility criteria
Qualifiers
18 years or older
Discharged after delivery at University of Minnesota Medical Center
Enrolled into the HOPE-BP Program
Disqualifiers
Ongoing antihypertensive medication use at 2 weeks (time of randomization)
Have a medical comorbidity that would not be clinically appropriate to randomize
Patients opted out of clinical research
Trial design
Treatments tested in this trial
- 2-Week Home Monitoring
- 6-Week Home Monitoring
Treatment groups
Locations
1Sponsors and collaborators
University of Minnesota
Lead sponsor